We subsequently formulated a more specific probe, [18F]CFA, which was Utilized in The existing study to evaluate dCK action in tumors when addressed with a small molecule dCK inhibitor. This probe is likewise being analyzed in the scientific trial at our institution to evaluate variations in dCK action following cancer immunotherapy 18. PET probes